L827-0112 Screening compound: 1-methyl-4-[5-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]piperazine

L827-0112 Screening compound: 1-methyl-4-[5-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]piperazine
L827-0112 Screening compound: 1-methyl-4-[5-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound L827-0112
1-methyl-4-[5-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L827-0112

Molecular Formula

C18H19N5O (C18 H19 N5 O)

Compound Name

1-methyl-4-[5-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]piperazine

IUPAC name

1-methyl-4-[5-(3-phenyl-124-oxadiazol-5-yl)pyridin-2-yl]piperazine

SMILES

CN(CC1)CCN1c(cc1)ncc1-c1nc(-c2ccccc2)no1

InChI

InChI=1S/C18H19N5O/c1-22-9-11-23(12-10-22)16-8-7-15(13-19-16)18-20-17(21-24-18)14-5-3-2-4-6-14/h2-8,13H,9-12H2,1H3

InChI Key

PFBIRCQPEJTISE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27478139

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

321.38

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.535

Distribution Coefficient, logD

2.965

Water Solubility, LogSw

-3.37

Polar Surface Area

47.174

Acid Dissociation Constant (pKa)

24.28

Base Dissociation Constant (pKb)

7.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

27.80

L827-0112 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

GPCR Targeted Library (31838 compounds)

SmartTM Library (51161 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L827-0112 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L827-0112?
Check Price and Availability of L827-0112, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L827-0112 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L827-0112
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L827-0112
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L827-0112 available by request